Kintor Pharmaceutical Ltd (HK:9939) has released an update.
Kintor Pharmaceutical Ltd has announced a change in its principal place of business in Hong Kong, effective November 1, 2024. The company will move to the 40th Floor of the Dah Sing Financial Centre in Wanchai, while maintaining its current contact information. This move could be of interest to investors keeping an eye on the pharmaceutical sector and its growth dynamics in Asia.
For further insights into HK:9939 stock, check out TipRanks’ Stock Analysis page.